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Introduction
INTRODUCTION 
 Chronic Kidney Disease (CKD) is a clinical syndrome due to 
irreversible renal dysfunction leading to excretory, metabolic and 
synthetic failure resulting in accumulation of nitrogenous waste products 
and presents with varied clinical manifestations. 
 End stage renal disease (ESRD) represents a clinical state in 
which there has been an irreversible loss of endogenous renal function, 
of a degree sufficient to render the patient permanently dependent upon 
renal replacement therapy in order to avoid life threatening uremia. 
 Inspite of varied etiologies, chronic kidney disease is the final 
common pathway of irreversible destruction of nephrons, ultimately 
resulting in "alteration of milieu interior" that affects every system in the 
body. One such system is thyroid hormonal system. Kidney is closely 
related to thyroid in the fact that it is the only other organ that competes 
for iodide clearance.(Ref. 25) 
 Patients with CKD have many symptoms and signs suggestive of 
thyroid dysfunction. These findings include dry skin, edema, sallow 
complexion, cold intolerance, low temperature, decreased basal 
metabolic rate, lethargy, fatigue and hyporeflexia. So in CKD patients, it 
is difficult to exclude the diagnosis of hypothroidism on clinical 
grounds.(Ref. 31) 
 Various studies of thyroid functions in uremic patients have been 
carried out which have shown conflicting results. Hyperthyroidism. 
hypothyroidism and euthryoid state have all been reported by various 
studies. (Ref. 1,19,24,26,29,30,32,38,41,47,48) Prevalence of hypothyroidism in end 
stage renal disease has been estimated to range between 0 and 9.5 per 
cent.(Ref.22,31) There is also increased prevalence of goitre in these 
patients. The incidence of goitre has also been variously reported in 
literature.(Ref. 28,34,40,41,48) 
 In view of the variability of thyroid function tests in patients with 
CKD in previous studies, it was decided to undertake a prospective 
clinical and biochemical study of thyroid functions on CKD patients in 
the Institute of Internal Medicine, Madras Medical College and 
Government General Hospital, Chennai. 
Aims and Objectives
AIMS AND OBJECTIVES 
1. To study the prevalence of thyroid dysfunction in CKD. 
2. To find out the types of thyroid dysfunction in CKD. 
3. To determine the correlation between the thyroid 
dysfunction and severity of renal disease. 
4. To identify the correlation between thyroid dysfunction and 
the severity of anemia in CKD. 
5. To differentiate primary thyroid disease from thyroid 
dysfunction due to chronic kidney disease.
Review of the 
Literature 
REVIEW OF THE LITERATURE 
PHYSIOLOGY OF THYROID HORMONES 
 Thyroxine (T4) and Triiodothyronine (T3) are the principle 
hormones produced by thyroid gland. 
 Initially iodine is absorbed in the gut and is converted to iodide 
and transported in the blood. It is then actively transferred into the 
thyroid cell by "Iodide trapping". The trapped iodide is oxidized to 
iodine and combines with tyrosine to form Mono iodotyrosine (MIT) 
and Diiodotyrosine (DIT). MIT and DIT are coupled to form T3 
whereas two DIT couple to form T4. Oxidation, Iodination and coupling 
reactions are catalyzed by "Thyroid Peroxidase". Thyroid hormones 
thus produced are bound with thyroglobulin until secreted. 
 Once secreted in the blood, it is transported in two forms. One is 
bound form in which T3 and T4 are bound to plasma proteins namely 
thyroid binding globulin, pre albumin and albumin. T4 is predominantly 
bound to thyroid binding globulin whereas T3 is predominantly bound 
to albumin. The other form is free T3 and T4. These free forms are in 
equilibrium with bound form. 
 In the periphery one third of T4 is converted to T3 by 5' 
Deiodinase and 45% to rT3 by 5 deiodinase. They  are further 
metabolised to Diiodothyronine. Only about 13% of T3 is produced 
from thyroid gland and remaining 87% is formed from T4. 
TABLE - A : VARIATIONS IN THYROID HORMONES AND 
BINDING PROTEINS IN HYPER AND HYPOTHYROIDISM 
Condition 
Concentrations 
of binding 
proteins 
Total 
Plasma T4, 
T3, rT3 
Free 
Plasma T4, 
T3, rT3 
Plasma 
TSH 
Clinical 
Status 
Hyperthyroidism Normal High High Low Hyperthyroid 
Hypothyroidism Normal Low Low High Hypothyroid 
 
CONTROL OF THYROID HORMONES 
 The thyroid stimulating hormone (TSH) controls the secretion of 
T3 and T4. It is secreted in a pulsatile manner with peak secretion at 
night. Its secretion is stimulated by thyrotropin releasing homrone 
(TRH). Both TRH and TSH release are under negative feedback of free 
T3 and T4. 
HYPOTHYROIDISM 
 Hypothyroidism is a clinical syndrome caused by decreased levels 
of thyroid hormones. It can be primary in which there is intrinsic 
disorder of thyroid gland or it may be secondary in which there is 
pituitary or hypothalamic defect. 
 Florid hypothyroidism can be diagnosed clinically. The symptoms 
of hypothyroidism in descending order of frequency are: 
 Tiredness, weakness 
 Dry skin 
 Feeling cold 
 Hair loss 
 Difficulty in concentrating and poor memory 
 Constipation 
 Weight gain with poor appetite 
 Dyspnea 
 Hoarse voice 
 Menorrhagia (Later amenorrhea) 
 Paraesthesia 
 Impaired hearing 
 The signs of hypothyroidism in descending order of frequency are 
as follows: 
 Dry coarse skin 
 Cool peripheral extremities  
 Puffy face, hands and feet (myxedema) 
 Diffuse alopecia 
 Bradycardia 
 Peripheral edema 
 Delayed tendon reflex relaxation 
 Carpal tunnel syndrome 
 Serous cavity effusions. 
In biochemical studies, TSH is the single most important 
parameter for screening hypothyroidism. A normal TSH level rules out 
primary hypothyroidism but not secondary. To diagnose primary 
hypothyroidism TSH level should be above 20 µIU/ml or at least above 
10µIU/ml if clinical features strongly suggest.  
In the presence of elevated TSH, low T4 especially free T4 is 
necessary to confirm hypothyroidism. Circulatory free T3 is usually 
reduced. But it may be normal in 25% of hypothyroid patients. So T3 
measurements are not reliable indicators of hypothyroidism. 
HYPERTHYROIDISM 
 Hyperthyroidism is a clinical syndrome which results from 
excessive circulating levels of free thyroid hormones. 
 The symptoms of hyperthyroidism in descending order of 
frequency are as follows: 
♦ Hyperactivity, irritability, dysphoria. 
♦ Heat intolerance and sweating  
♦ Palpitations 
♦ Fatigue and weakness 
♦ Weight loss with increased appetite 
♦ Diarrhea 
♦ Polyuria 
♦ Oligomenorrhea, loss of libido 
The signs of hyperthyroidism in descending order of frequency 
are follows: 
! Tachycardia; Atrial fibrillation in the elderly 
! Tremors 
! Goitre 
! Warm, moist skin 
! Muscle weakness, proximal myopathy 
! Lid retraction or lid lag 
! Gynaecomastia 
Laboratory investigations show TSH levels below normal. Free 
and total thyroid hormone levels are increased. 
In 2 to 5% of patients, only T3 is increased and T4 is normal. This 
condition is called "T3 thyrotoxicosis". Occasionally total and free T4 
will be increased with normal T3 level. This condition is called "T4 
thyrotoxicosis". 
NON THYROIDAL ILLNESS(Ref. 6,8,20,37,43,46) 
Alteration in serum thyroid hormones occurs in wide variety of 
illness which predominantly affect the T3 level and no intrinsic disease 
of thyroid gland is detected. It is variously termed as Low T3 syndrome, 
Sick euthryoid syndrome, Non thyroidal illness syndrome and Thyroid 
hormone adaptation syndrome. 
This syndrome occurs in wide variety of illness as follows: 
i. Acute critical illness and febrile illness such as infections, 
myocardial infarction etc. 
ii. Injuries such as burns, trauma, etc. 
iii. Surgery 
iv. Fasting 
v. Diabetes mellitus 
vi. Liver disease 
vii. Renal disease 
viii. Ketogenic diet 
ix. Drugs such as glucocorticoids, dopamine, phenytoin and 
beta blockers 
x. Malignancy 
xi. Psychiatric illness 
In non thyroidal illness state, initially there is decrease in serum 
T3 level, both total and free T3 (FT3). This is associated with increase 
in reverse T3 (rT3). 
As illness progresses, there is decrease in serum T4 also, a state 
called "Low T3, T4 syndrome". Although total T4 level decreases, the 
free T4 (FT4) remains normal or slightly reduced. Inspite of this reduced 
T3 and T4 level, serum TSH level remains normal or reduced, by which 
it is differentiated from primary hypothyroidism. But many studies have 
showed slight elevation of TSH level in Non thyroidal illness in the 
absence of hypothyroidism.(Ref. 7,21,26) 
CHRONIC KIDNEY DISEASE 
Pathophysiology 
 The unique property of the kidney is that in the presence of CKD, 
compensatory and adaptive mechanisms maintain acceptable health until 
the GFR is around 10 to 15 ml/min and life sustaining renal excretory 
and homeostatic functions continue until the GFR is above 5 ml/min. 
Intact Nephron Hypothesis 
 The explanation proposed for these adaptive mechanism is that, in 
CKD there is progressive loss of nephrons, so most of the nephrons are 
non functioning. The remaining few functioning nephrons tend to hyper 
function and take an increased work load so that the overall loss of 
function is minimized. This indicates that GFR of the individual 
functioning nephrons have increased above normal, a state know as 
hyperfiltration. This increase in single nephron GFR in the functioning 
nephrons produce an increased volume of filtrate and their tubules 
respond appropriately by excreting fluids and solutes in amounts which 
maintain external balance. This is due to close integration of glomerulus 
and tubular function called "glomerulo tubular balance", which is  
present until the terminal stages of CKD. These above stated popular 
explanations for continuing function in the remaining nephrons, is 
referred to as the "intact nephron hypothesis".  
Trade Off Hypothesis 
 It is described that the adaptation arising in CKD may control one 
abnormality, but only in such a way so as to produce other changes 
characteristic of uremic syndrome. The mechanism involved is 
unknown. This trade off hypothesis is described in hormones like 
parathormone, vasopressin, atrial natriuretic peptide and solutes like 
iodide, potassium, phosphate and others. 
Uraemic Syndrome 
 Uraemic syndrome is a consequence of combination of the effects 
of the retention of waste products in all organ system and the failure of 
endocrine and homeostatic functions of the kidney. 
 These patients manifest with symptoms like fatigue, dyspnoea, 
facial puffiness, ankle swelling, anemia, vomiting, pruritus, polyuria, 
nocturia etc. 
 The potential toxic substances that accumulate include purine 
metabolites, amines, indoles, phenols, myoinositol and acid polyols. 
 "Middle molecules" are nitrogenous substances of molecular 
weight between 50 and 5000 Da. They are suspected to contribute to 
uraemia. 
CHRONIC KIDNEY DISEASE PRESENTING AS NON 
THYROIDAL ILLNESS 
 Chronic kidney disease is one among the several conditions 
causing "Low T3 syndrome". 
 Chronic kidney disease has been divided into five stages based on 
the endogenous creatinine clearance. A typical patient with chronic 
progressive renal disease may be considered to pass through all five 
stages. 
Stage - I  
 Presence of objective kidney damage with increased GFR. GFR is 
more than 90 ml/min. 
Stage - II 
 Presence of kidney damage with mild decrease in GFR. GFR is 
60-89 ml/min. 
Stage - III 
 Moderate decrease in GFR. GFR is 30 - 59 ml/min with or 
without objective evidence of kidney damage. 
Stage - IV 
 Severe reduction in GFR 15-29 ml/min. 
Stage - V 
 GFR less than 15 ml/min. 
 As with other low T3 syndrome, CKD produces decrease in T3 
when GFR falls below 50%. As the GFR decreases the reduction in T3 
is more marked than T4. In ESRD, on an average, diminished T4 is 
found in 29% of the patients and diminished T3 in 55% of the 
patients.(Ref. 31)  
TABLE - B : CHANGES IN SERUM THYROID HORMONES 
AND TSH CONCENTRATION IN PATIENTS WITH NON 
THYROIDAL ILLNESS 
Conditions 
Serum 
T3 
Serum 
rT3 
Serum 
T4 
Serum  
Free T4 
Serum 
TSH 
Fasting ↓ ↑ = = ↓ 
Mild Illness ↓ ↑ = =, ↑ = 
Critical Illness ↓ ↑ ↓ =, ↓ ↓ 
Surgery, Trauma, 
Burns 
↓ ↑ ↓ ↓ =, ↓ 
Chronic Kidney 
Disease 
↓ = =, ↓ =, ↓ =,↓ 
Hepatitis =, ↑ =, ↑ =, ↑ =, ↓ = 
HIV infection = ↓ = =, ↓ =, ↑ 
Depression =, ↓ =, ↑ =, ↑ =, ↑ =, ↓ 
 
 = No Change, ↓ Decreased, ↑ Increased  
The low T3 syndrome in CKD differs from other conditions 
causing similar illness by two unique features.(Ref. 37) 
i. rT3 is usually low or normal in CKD due to redistribution into the 
extra vascular compartment. Some unknown factor in uremia 
stimulates the uptake of rT3 into the liver. (Ref.16) 
ii. Increased incidence of goiter is present in CKD, Probably due to 
decreased clearance of iodine by the kidney. 
PATHOPHYSIOLOGY OF LOW T3 SYNDROME 
 As stated above in CKD there is initial decrease in total T3, later 
T4 inspite of normal or low TSH. Various mechanisms have been 
proposed for the changes in thyroid profile. 
 According to the postulates, CKD affects thyroid homeostasis at 
all levels as follows: 
a. Changes in Hypothalamic - Pituitary - thyroid axis 
i. Sensitivity of TSH Secretion to low thyroid hormones is 
decreased.(Ref. 7,12,36,37,46) 
ii. Limited TSH reserve.(Ref.37) 
iii. Decrease in nocturnal pulses of TSH secretions is either 
due to changes in thyrotrophs or due to deceased TRH 
secretion.(Ref. 3,13,46) 
iv. Tissue concentration of the hormone may be appropriate 
for the patient, so the patient is in euthyroid state.(Ref. 37) 
v. Serum FT3 and FT4 appears normal by sensitive 
methods.(Ref.2,15) 
b. Changes in Hormone Transport  
i. Presence of protein and non protein inhibitors prevent the 
binding of thyroxin with thyroxin binding protein. Non 
protein inhibitor is non esterified unsaturated fatty 
acid.(Ref.18,46) 
ii. Acquired intrinsic structural alteration in the T4 binding 
site.(Ref.20) 
iii. Decrease in the concentration of thyroxine binding 
globulin.(Ref.37,46) 
c. Changes in Metabolism 
i. Decrease in the activity of Iodothyronine - 5 - Deiodinase 
leading to low T3.(Ref.37,46) 
ii. Increase in Non-deiodinative pathways of iodothronine 
degradation leading to increase serum T3 sulphate, 
diiodothyronine, triiodo thyroacetic acid and tetra 
iodothryoacetic acid.(Ref. 37,46) 
iii. As stated previously, there is no increase in rT3 in CKD 
due to increased uptake of rT3 by liver.(Ref.16,37,46) 
d. Change in Plasma Membrance Transport 
 T3 and T4 may enter cells not only by diffusion but also by active 
energy dependent transport across plasma membrane. 
 Accumulation of the following substances prevent uptake and 
subsequent deiodination.(Ref.46) 
 (i) 3-Carboxy 4-methyl 5- propyl 2- Furane (CMPF) 
 (ii) Indoxyl sulphate 
 In uraemia the activity of thyroid hormones at nuclear level are 
not compromised. A Recent study showed increased receptor expression 
to preserve tissue euthyroidism.(Ref.45) 
DIAGNOSIS OF PRIMARY THYROID DISEASES IN CKD 
 Recent studies have shown that the prevalence of hypothyroidism 
is increased in chronic kidney disease. Several clinical features of both 
hypothyroidism and CKD are similar. So differentiating both the 
conditions on clinical background is less likely. Hence all the CKD 
patients with symptomatology of hypothyroidism should be screened for 
hypothyroidism. 
 Hypothyroidism should be diagnosed only if the following 
prevails. 
 a. Basal TSH level should be elevated more than 20 µIU/ml. 
b. Both total and free T4 are distinctly low in the presence of 
normal TBG.(Ref.31) 
c. Presence of antithyroid antibodies provide a clue for 
hypothyroidism.(Ref.31) 
d. rT3 is not useful because it is decreased in CKD. 
Primary hyperthyroidism is very rare in CKD. This condition is 
diagnosed by 
a. Low serum TSH 
b. High serum total and free T4 concentration 
 High serum T4 with low T3 in the presence of CKD should raise 
the suspicion of T4 thyrotoxicosis. This is because serum T3 level will 
be suppressed in low T3 syndrome with serum T4 unaffected.(Ref.46) 
MANAGEMENT  
 Several studies have been conducted in patients with low T3 
syndrome in order to correct the thyroid profile by treating with L-
thyroxine(Ref.14) and triiodothyronine.(Ref.5) 
 Gregory Brent et al., conducted a study in non thyroidal illness  
patients by treating all the patients with serum total T4 less than 5 mIU/l 
with 1.5. µg/kg of L-thyroxine for 2 weeks. Thyroxine level increased 
significantly in treated patients. Serum T3 levels was also raised. But 
mortality was increased in treatment groups on days 5-17. 
 Carter et al., studied effects of Triiodothyronine administration in 
patients with CKD. Study showed serum T3 level did not change over a 
period of 12 weeks. But the mean serum T4 and TSH levels were 
affected significantly. There was no subjective improvement in these 
patients. 
 Based on this observation it has been suggested that low serum T3 
level in patients with severe renal failure is metabolically protective and 
it is interpreted as physiological adaptation to reduced basal metabolic 
rate and to conserve energy in an adverse environment. Hence this 
condition has been renamed as "Thyroid hormone adaptation 
syndrome"(Ref.46) 
 Administration of T4 or T3 causes suppression of TSH and 
increases the catabolism. So administration of thyroid hormone is not 
beneficial. Study also showed increased mortality with the treatment. 
Therefore thyroid hormones should not be given in CKD unless true 
hypothyroidism is documented. 
PROGNOSIS 
 Magnitude of the thyroid dysfunction that occurs in patients with 
chronic kidney disease, in general, reflects the severity of the illness. 
The prognosis is poor in patients with lower serum T3, T4 or TSH 
concentration. Studies have shown that after renal transplantation the 
low T3, T4 and TSH returns to normal level.(Ref.48) 

Materials and 
Methods
 MATERIALS AND METHODS 
SETTING 
 The study was conducted in the inpatients admitted in the Institute 
of Internal Medicine, Madras Medical College and Government General 
Hospital, Chennai. 
STUDY DESIGN 
 Single Center 
 Non Randomized prospective study 
STUDY PERIOD 
 Study was conducted between September 2005 and August 2006 
for a period of 12 months. 
SAMPLE SIZE 
 In the study period of 12 months among the patients admitted in 
internal medicine wards after applying inclusion and exclusion criteria 
75 patients were included in this study. 
 The patients who fulfilled the criteria for CKD and who were on 
conservative management were taken into the study.  
 Criteria for chronic kidney disease: 
 1. Presence of objective kidney damage for at least three 
months. Kidney damage being defined as pathologic abnormalities or 
markers of damage including abnormalities in blood or urine tests or 
imaging studies. Imaging study is usually an ultra sonogram abdomen 
showing. 
 a. Bilateral contracted kidneys, or; 
 b. Poor corticomedullary differentiation or; 
 c. Type II or type III Renal parenchymal changes or; 
 2. Glomerular filtration rate (GFR) less than 60ml/min/1.73m2 
for at least three months with or without kidney damage. 
INCLUSION CRITERIA 
 CKD patients who were on conservative management. 
EXCLUSION CRITERIA 
 i. Patients with Acute Renal failure (ARF) 
ii. CKD patients who underwent peritoneal dialysis or 
hemodialysis. 
 iii. CKD due to diabetes mellitus  
 iv. Patients with documented hypothyroidism 
v. Patients on beta blockers, amiodarone, steroids, dopamine, 
phenytoin and iodine therapy. 
 vi. Other conditions like  
Acute illness  
Recent surgery, Trauma and Burns. 
 Detailed clinical history was taken from all the patients who were 
included in the study. History focused on symptoms of hypothyroidism 
like fatigue, weakness, dry skin, cold intolerance, constipation, weight 
gain, hoarse voice, menstrual disturbances. Past history of hypertension, 
diabetes mellitus, any drug intake, history of recent surgery, trauma, 
jaundice and other systemic illness was taken. 
 After taking detailed history, all the patients were examined 
clinically in detail. Their height and weight was measured. A detailed 
General Examination was done including Nourishment, pallor, facial 
puffiness, pedal edema and skin texture. Presence of thyroid swelling 
(Giotre) was noted. 
 Vital signs like pulse, blood pressure, temperature were taken. All 
the systems were examined carefully including fundus oculi and deep 
tendon reflex to find out the delayed relaxation of Ankle jerk. 
 The following investigations were performed: 
i. Blood hemoglobin level to find out the degree of Anemia. 
ii. Peripheral smear study to look for pallor and the presence 
of burr cells. 
iii. Urine examination for the presence of albumin and pus 
cells. 
iv. Blood sugar was estimated to find out the presence of 
diabetes mellitus. 
v. Renal parameters like serum urea and creatinine were done. 
From serum creatiatine value using Cockcroft - Gault 
formula, creatinine clearance was calculated. 
vi. Serum levels of calcium and phosphorous were estimated. 
vii. Chest X ray and electrocardiogram to look for features of 
hypothyroidism and renal failure like pericardial effusion, 
pleural effusion etc. 
viii. Ultransonogram abdomen for features of chronic kidney 
disease.  
ix. Serum cholesterol levels for hypothyroidism. 
x. Liver function tests especially serum albumin level to find 
out any hypoalbuminemia in the patients. 
 After selecting the patients fulfilling the above criteria for the 
study, about 5 ml of blood sample was collected in a non heparinised 
sterile bottle and sent for thyroid profile. 
 Components of thyroid profile in this study: 
 Serum Triiodothryonine (T3) 
 Serum Thyroxine (T4) 
 Serum Thyroid Stimulating Hormone (TSH) 
 Quantitative determination of the serum T3, T4 and TSH was 
done by Radio Immuno Assay / Immuno Radio Metric Assay. 
 The Normal values are 
 T3 - 0.7 to 2.0 ng/ml 
 T4 - 5.5 to 13.5 µg/dl 
 TSH - 0.17 to 4.05 µIU/ml 

Results and 
Observations 
RESULTS AND OBSERVATIONS 
 Among the 75 patients included in our study 60 patentees were 
men accounting for 80% of the total cases. The remaining 15 patients 
were (20%) women. 
 According to the age, patients of less than 30 years were 11 in 
number (14.67%). Majority of the patients were in the age group 
between 30 and 60. 52 patients (69.33% of study population) were in 
this group. 12 patients (16.0%) were above the age of 60. 
 The creatinine clearance in this study was ranging from 7 ml/min 
to 38 ml/min. Patients were grouped into four groups for the purpose of 
further analysis based on creatinine clearance. Patients with GFR of 10 
and below were 14 in number. GFR of 11 to 20 were 38 patients. GFR 
between 21 and 30 were 11 patients and 12 patients had GFR more than 
30. 
 Blood urea in our study ranged from 65 of 185 mg/dl. Creatinine 
was in the range of 2.2 to 14.7 mg/dl. 
 Ultrasound abdomen showed evidence of CKD in all the 75 
patients. Bilaterally contracted kidneys were present is 65 (86.7%) 
patients. Remaining 10 patients (13.3%) had poor Cortico medullary 
differentiation. 
 Among the 75 patients, low serum T3 level was found in 40 
patients (53.3%). Eight patients among the low serum T3 level also had 
high TSH value of more than 20 µIU/ml with low T4 level and also 
symptoms suggestive of hypothyroidism. These patients as per the 
criteria were grouped under "Primary hypothyroidism". 
 14 patients had slightly elevated TSH ranging between 5 and 20 
µIU/ml. Eight patients had TSH in the range of 10 to 20 µIU/ml. In the 
eight patients only five patients had low T4 level, among which only 
one patient had few clinical features of hypothyroidism. So these 
patients did not satisfy the criteria for hypothyroidism. So all the 
remaining 32 patients were grouped under "Low T3 Syndrome". 
TABLE - 1 SERUM CONCENTRATION OF THYROID 
PROFILE 
Thyroid Profile Normal Range 
Study 
Range Mean 
Std. 
Deviation 
Mean Excluding 
Hypothyrodism 
Std. 
Deviation 
Serum T3 ng/ml 0.7-2.0 0.2.-2.0 0.68 0.45 0.72 0.46 
Serum T4µg/dl 5.5-13.5 0.8-9.2 5.70 2.22 6.12 1.94 
Serum TSH µIU/ml 0.17-4.05 0.5-28.5 5.91 7.80 3.54 3.77 
 
TABLE - 2 : DISTRIBUTION OF THYROID PROFILE IN OUR 
STUDY 
Thyroid Status No. of Patients  Percent 
Hypothyroidism 8 10.67 
Low T3 Syndrome 32 42.67 
No Thyroid Dysfunction  35 46.67 
 
TABLE - 3 DISTRIBUTION OF THYROID DYSFUNCTION IN 
THE STUDY 
Thyroid Dysfunction No. of Patients  Percent 
Low T3 Syndrome 32 42.67 
Low T4 Syndrome 16 21.33 
Hypothyroidism 8 10.67 
 
HYPOTHYROIDISM IN CKD 
 Symptoms of hypothyroidism like tiredness, somnolence, weight 
gain, cold intolerance, constipation, hoarse voice etc were studied in 
CKD. In our study population, 45 patients (60%) had the symptoms of 
hypothyroidism (Table - 4). Among the 45 patents, all the eight 
hypothyroid patients had the symptoms.16(50%) of the 32 low T3 
syndromes patients had hypothyroid symptoms. In CKD without thyroid 
dysfunction, 21patients (60%) had the symptoms. 
TABLE - 4 ANALYSIS OF HYPOTHYOID SYMPTOMS IN CKD 
Variants No. of Patients with Hypothyroid Symptoms  Percent 
Low T3 Syndrome (n=32) 16 50 
Hypothyroidism (n=8)  8 100 
CKD without thyroid 
dysfunction (n=35) 
21 60 
 
 Sinus bradycardia was present in nine patients of which three 
patients were hypothyroid both clinically and biochemically. Delayed 
ankle jerk was present in 11 patients of which only 2 patients were 
hypothyroid. 
 Hypothyroidism did not show any linear correlation with GFR. 
Maximum number of hypothyroid patients of four in number were 
present in GFR 11-20 ml/min group whereas two patients each were 
found to be hypothyroid in the GFR less than 10 and 21-30 ml/min 
group. No patients were hypothyroid in GFR greater than 30 ml/min 
group. 
 In our study diffuse thyroid swelling was present in 3 patients. 
Two of these patients had normal serum T3 and T4. One patient had low 
serum T3 and T4 with normal serum TSH. 
 Age comparison of low T3 syndrome patients in table 5 shows 
about 40.0% of CKD patients below 30 years of age have low T3 
syndrome. The percentage increases to 52.2% in the age group 31-60 
years. This is probably due to high number of CKD patients who are in 
this age group. In the age above 60 years 36.4% have low T3 Syndrome. 
TABLE - 5 : AGE INCIDENCE OF LOW T3 SYNDROME 
EXCLUDING  HYPOTHYROIDISM 
Age (in years) Number of Patients 
Low T3 
Syndrome Percent 
≤ 30 10 4 40.0 
31-60 46 24 52.2 
> 60 11 4 36.4 
 
P Value 0.556 
(Not significant) 
TABLE - 6 : SEX INCIDENCE OF LOW T3 SYNDROME 
EXCLUDING  HYPOTHYROIDISM 
Sex 
Number of 
Patients 
Low T3 
Syndrome 
Percent 
Male 54 (80.6%) 25 46.3 
Female 13 (19.4%) 7 53.8 
 
P Value 0.624 
(Not significant) 
 Sex incidence in this study (Table - 6) show that 46.3% of males 
have low T3 syndrome and 53.8% of females have low T3 syndrome 
after excluding hypothyroid patients in the analysis. 
TABLE - 7 : RESULTS OF SERUM T3, T4 AND TSH 
EXCLUDING  HYPOTHYROIDISM 
Thyroid 
Profile 
No of Pts. with 
below normal 
value 
% 
No of pts. 
with normal 
value 
% 
No of Pts. with 
above normal 
value 
% 
T3 32 47.76 35 52.24 - 0 
T4 16 23.88 51 76.12 - 0 
TSH - 0 53 79.10 14 20.90 
 
TABLE - 8 DISTRIBUTION OF SERUM T3 AND T4 
Serum T3 Serum T4 
Normal T3 Low T3 Syndrome Normal T4 
Low T4 
Syndrome 
Creatinine 
Clearance 
ml/min 
No of 
Pts. % 
No of 
Pts. % 
No of 
Pts. % 
No of 
Pts. % 
≤ 10 3 25 9 75 8 66.7 4 33.3 
11-20 16 47.1 18 52.9 25 73.5 9 26.5 
21-30 6 66.7 3 33.3 6 66.7 3 33.3 
> 30 10 83.3 2 16.7 12 100 0 0 
Statistical 
Significance 
* P.0.025 P Value 0.177  
Not significant 
 
Note * denote significant at 5% level 
Observation of T3 in the Study 
 T3 level in this study varied from 0.2 to 2.0 ng/ml. The mean 
value of T3 is 0.68 ng/ml (Table - 1). Excluding the patients with 
primary hypothyroidism,  the mean value was 0.72 ng/ml. This value is  
within the low normal limit. The patients with low serum T3 (low T3 
syndrome) were analysed with creatinine clearance. In patients with 
creatinine clearance above 30 ml/min were having low T3 syndrome 
only in 16.7%. This rises to 33.3% and 52.9% in creatinine clearance 
21-30, 11-20 groups respectively. (Table - 8). Patients with less than 10 
ml/min creatinine clearance had 75% incidence of low T3 syndrome. 
This progressive increase in the incidence of low T3 syndrome as the 
renal failure progresses is statistically significant at 5% level with a P 
value of 0.025. 
 Excluding hypothyroidism, serum T3 levels were studied in 
relation to creatinine clearance  (Table - 9). The mean value 
progressively decreases as the renal failure progresses with statistical 
significance in Tukev - HSD test at 1% level, the P value being 0.002. 
 None of the patients had serum T3 levels above the normal. 
TABLE - 9 CORRELATION OF THYROID PROFILE WITH 
SEVERITY OF RENAL FAILURE EXCLUDING 
HYPOTHYROIDISM 
Creatinine 
Clearance 
ml/min 
Mean 
T3 
ng/ml 
Std. 
Deviation 
Mean 
T4 
µg/dl 
Std. 
Deviation 
Mean 
TSH 
µIU/ml 
Std. 
Deviation 
≤ 10 (n=12) 0.45 0.28 5.33 2.27 3.98 4.42 
11-20 (n=34) 0.64 0.40 6.02 1.99 3.26 3.76 
21-30 (n=9) 0.92 0.45 5.86 1.72 3.41 3.81 
> 30 (n=12) 1.05 0.53 7.38 0.97 3.97 3.50 
Statistical 
Significance 
** P Value 0.002  P Value 0.061  
Not Significant 
P Value 0.921  
Not significant 
 
Note ** denotes significant at 1% level. 
(Significant with Tukev - HSD test) 
Observation of T4 in the Study 
 Serum T4 level in the study varies from 0.8 to 9.2 µg/dl. Mean 
value of serum T4 among the 75 patients is 5.70 µg/dl. Excluding 
hypothroid patients the mean value is 6.12 µg/dl. This value is within 
low normal level of T4. 
 Excluding 8 hypothyroidism patients who have  low T4 values, 16 
(21.33%) other patients had T4 level below normal and low T3 
syndrome. 
 Number of patients with low T4 does not correlate with severity 
of renal disease (Table 8). The mean value of T4 excluding  
hypothyroidism patients was normal at all the stages of renal failure 
(Table - 9) except, when the creatinine clearance was below 10 mg/ml 
where it was below normal. The mean serum T4 was not significant 
with severity of renal disease, P value being 0.061. 
 None of the patients had T4 value above normal level. 
Observation of TSH in the Study 
 The value of TSH varied from 0.5 to 28.5 µIU/ml with the mean 
of 5.91 µIU/ml. Excluding hypothyroidism the mean TSH value is 3.54 
µIU/ml. This is in normal range. 
 In spite of low serum T3 level in 40 (53.33%) patients, serum 
TSH is normal in 53. (70.67%) patients and valued between  
4-20 µIU/ml is present is 14 (18.67%) patients.  It is elevated more than 
20 µIU/ml in 8 (10.67%) patients. 
 In our study the mean value of serum TSH is within normal limits 
in all groups of progressive renal disease (Table - 9). The values of TSH 
did not show any linear correlation with creatinine clearance. 
TABLE - 10 DISTRIBUTION OF SERUM T3 AND T4 WITH 
HEMOGLOBIN LEVELS 
Serum T3 Serum T4 
Normal T3 Low T3  Normal T4 Low T4  Hemoglobin 
g/dl 
No of 
Pts. % 
No of 
Pts. % 
No of 
Pts. % 
No of 
Pts. % 
≤ 6 1 16.7 5 83.3 3 50.0 3 50.0 
6.1-8 7 33.3 14 66.7 14 66.7 7 33.3 
8.1-11 22 68.8 10 31.3 28 87.5 4 12.5 
> 11 5 62.5 3 37.5 6 75.0 2 25.0 
Statistical 
Significance 
* P.0.019 P Value 0.113  
Not significant 
 
Note * denote significant at 5% level 
Hemoglobin Level and its Correlation with Thyroid Profile in the 
Study 
 Anaemia was almost universal in our study in chronic kidney 
disease. Among the 75 patients, 65 of the patients had hemoglobin 
values less than 11g/dl. Patients hemoglobin values correlated with the 
severity of renal disease.  
 On analysing patients with low T3 levels with Hemoglobin 
values, as the hemoglobin level decreases, the percentage of patients 
having low T3 increases. (Table - 10). This is significant with  
P value of 0.019. When compared with low serum T4, hemoglobin 
values are not significantly related. 
When correlating mean serum T3 and T4 with severity of  anemia 
(Table - 11), as the hemoglobin declines, the mean T3 values also 
decreases. Serum mean T3 is 0.94 in the hemoglobin more than 11 
group. It is 0.84, 0.54, 0.37 ng/ml in hemoglobin 8.1 - 11, 6.1-8, < 6 g/dl 
groups respectively. This is significant with P value of 0.010. 
Mean serum T4 also has a linear correlation with hemoglobin 
level. The mean value of T4 is 6.35 µg/dl in hemoglobin more than 11 
g/dl patients. It is 6.82 µg/dl in the hemoglobin 8.1 -  11 g/dl group, 
which may be because of the increased number of patients in this group. 
The mean T4 decreases linearly with decreased level of hemoglobin. It 
is 5.44 µg/ml and 4.48 µg/dl corresponding to hemoglobin 6.1-8 g/dl 
and <6 g/dl respectively. This relationship is statistically significant with 
P value of 0.009.   
TABLE - 11 CORRELATION OF THYROID PROFILE WITH 
SEVERITY OF ANAEMIA EXCLUDING HYPOTHYROIDISM 
Serum T3 Serum T4 
Hemoglobin g/dl 
Mean  
Std. 
Deviation 
Mean  
Std. 
Deviation 
< 6 0.37 0.23 4.48 2.63 
6.1 - 8 0.54 0.30 5.44 1.79 
8.1 - 11 0.84 0.48 6.82 1.60 
> 11 0.94 0.56 6.35 2.03 
P value 0.010** 0.009** 
 
Note ** significant at 1% level. 
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Discussion 
DISCUSSION 
 Thyroid dysfunction in chronic kidney disease was studied by 
various authors. All the studies conducted till now do not reveal  
consistent results. 
 Thyroid dysfunction in CKD was extensively studied by Ramirez 
et al.(Ref.34,35) He studied thyroid abnormalities and he extensively 
researched about hypophyseal abnormalities in uremia. He compared 
CKD patients on conservative management and hemodialysis. His 
studies revealed low T3 and T4 levels. TSH was within normal limits. 
His study showed linear correlation between the mean T3 andT4 and 
severity of renal failure. TSH does not show any linear correlation with 
severity of renal failure. 
 Avasthi G et al., from Ludhiana studied thyroid function in 
patients of chronic kidney diseases.(Ref.1)  Mean serum T3 and T4 values 
were significantly deceased in his study. This study revealed high serum 
TSH levels suggesting maintenance of pituitary thyroid axis. This result 
is comparable with Joseph et al., study.(Ref. 29) In contrast, Spector et 
al.,(Ref.41) and Ramirez et al.,(Ref.34) reported normal levels of serum TSH 
in patients of CKD in spite of low serum T3 levels. They demonstrated 
abnormality in the hypophyseal mechanism of TSH release in uremia 
patients as the TSH response to the administration of thyrotropin 
releasing hormone (TRH) was blunted. 
 PD Rath and PK Padhi from Cuttack did a study on thyroid 
function status in chronic kidney disease on conservative 
management.(Ref. 32) They concluded both serum T3 and T4 were 
deceased, TSH was not significantly increased. 
 Joseph LJ, Mehta HJ from Bombay conducted a study on total 
and free thyroid hormone levels in CKD.(Ref.29) They had taken thyroid 
profile in 127 CKD patients. Their results showed decreased T3 and T4 
with no significant change in TSH value. This study's results are 
consistent with the results of Xess A and Gupta A from Patna's study on 
evaluation of thyroid hormones in CKD.(Ref.47) They analysed 62 patients 
on conservative management and 34 patients on chronic hemodialysis. 
They also concluded that chronic hemodialysis did not have a positive 
effect in alteration of serum T3, T4 and TSH levels. 
 Spector DA et al., studied 38 patients with CKD for thyroid 
function and metabolic state.(Ref.41) Mean values for serum T4 and T3 
were within normal limits. But 43% of the patients had low serum T3. 
Serum TSH concentrations were normal. 
 Kayimo JE et al., from Nairobi, Kenya conducted a study in 52 
patients with CKD.(Ref.26) This study results showed T3 and T4 were low 
and TSH levels were significantly higher. 
 Kaptien EM et al., from Los Angles, USA studied thyroid 
hormone metabolism and thyroid disease in CKD.(Ref.23) In his study, 
serum T3 and T4 are reduced, with blunted TSH response to TRH. He 
concluded dialysis therapy minimally affects thyroid hormone 
metabolism and thyroid hormone metabolism normalises with renal 
transplantation. 
 In our study patients only on conservative management were 
studied. This is because thyroid profile undergoes changes due to 
dialysis. 
 In our study 53.3% of the patients have thyroid profile 
abnormalities. Remaining 46.7% of patients had normal thyroid profile. 
Among the patients with  thyroid dysfunction hypothyroidism is present 
in 10.7% of patients. Excluding the primary hypothyroidism patients 
42.7% of patients have decreased serum T3 values (low T3 syndrome). 
Among these low T3 syndrome patients 21.3% of patients also have 
decreased serum T4 value (low T4 syndrome). The percentage of patient 
who have low T3 syndrome increases with the decrease in creatinine 
clearance, which is statistically significant. The increase of low T4 
percentage does not show this linear relationship with creantinine 
clearance. 
 Many studies conducted in CKD patients showed low T3 
values.(Ref. 1,2,17,27,34,39,41) Low T4 had been reported in Ramirez et al., 
Hegedus et al., Backett et al., studies. 
 In our study the mean T3 value is below normal limit. After 
Excluding hypothyroidism patients the mean T3 value is within low 
normal limits. Mean T3 value progressively decreases with decline in 
creatinine clearance. This mean T3 value has a linear correlation with 
severity of renal disease which is statistically significant. This linear 
correlation between mean T3 and severity  of renal failure is consistent 
with the studies of Ramirez et al., and Spector et al. 
 The mean T4 level in our study is below normal in creatinine 
clearance less than 10 ml/min group. In all other levels of creatinine 
clearance the mean T4 value is in low normal level and T4 does not 
correlate with the severity of renal failure. This is consistent with 
Avasthi et al., study. 
 Excluding hypothyroidism mean TSH level in our study is within 
normal limits. The mean TSH levels are also within normal limits for 
the various ranges of creatinine clearance. The TSH level does not show 
any linear correlation with the severity of renal failure. This is consistent 
with the studies of Spector et al. and Ramirez et al. 
 In our study excluding those with hypothyroidism, 14 patients 
have slightly elevated TSH. Eight patients had TSH in the range of 10 to 
20 µIU/ml. In these eight patients only five have low T4 levels, among 
them only one patient had few clinical features of hypothyroidism. 
Investigation like free T4, Free T3, TRM response and antithyroid 
antibodies can be done to diagnose hypothyroidism in these patients. 
 In our study anemia was almost universal in CKD patients. The 
degree of anemia had a linear correlation with both mean T3 and mean 
T4 values which were statistically significant. 
 Our study was consistent with the results of Ramirez et al., study 
showing low T3, low T4 and normal TSH. From the various studies it 
has been suggested that these thyroid profile derangements are part of 
the body adaptation mechanism. 
Dialysis 
 Hemodialysis and continuous ambulatory peritoneal dialysis have 
shown to affect the thyroid profile independently of CKD. Also drugs 
like heparin, frusemide used during dialysis will affect the thyroid 
profile. 
 Kayima et al., and Giardana et al., have conducted studies on the 
effect of dialysis on CKD patients with thyroid dysfunction. These 
studies showed no significant improvement in thyroid profile after 
repeated hemodialysis. 
 But in patients who had undergone renal transplant surgery. Most 
of the thyroid function parameters returned to normal with TSH below 
normal.(Ref. 4,42) 
Hypothyroidism  
 Previous studies conducted in patients with CKD, reported 
increased prevalence of hypothyroidism. Quion Verde et al., reported 
about 5% prevalence with terminal renal failure.(Ref.33) 
 Study by Kaptien et al., estimated the prevalence of primary 
hypothyroidism in CKD was about 2.5 times more frequent. The 
hyperthyroidism in CKD was estimated to range between 0 and 9.5% 
Kaptein study also estimated the presence of antithyroid antibody in 
6.7% of CKD patients. 
 In our study hypothyroidism was present in 10.67% of patients. 
The prevalence of hypothyroidism does not correlate with the severity of 
renal failure. The symptoms of hypothyroidism are present both in CKD 
with hypothyroidism patients and in CKD patients without 
hypothyroidism. 
 So diagnosis of hypothyroidism in CKD mainly relies on TSH 
level which should be more than 20 µIU/ml with low serum T4. 
 In this study no patient had clinical or biochemical features of 
hyperthyroidism. 
Goitre 
 Remirez et al., reported high prevalence of goitre in CKD. The 
incidence of goitre has also been variably reported in various 
studies.(Ref.1,28,34,41,48) The possible explanations for the increased 
incidence is due to accumulations of iodides in thyroid gland due to 
decreased renal clearance in CKD patients. Apart from goitre study 
conducted by Hegedus et al., showed thyroid gland volume was 
significantly increased in patients with CKD.(Ref.17) 
 In our study only 3 patients had goitre but without clinical or 
biochemical features of hypothyroidism. Two of the patients had normal 
serum T3 and T4. One patient had low T3 and T4 with normal TSH . 
The number of patients with goitre in our study was statistically 
insignificant. 

Conclusions
CONCLUSIONS 
1. Thyroid dysfunction occurs both clinically and biochemically in 
CKD. 
2. Thyroid dysfunction occurs in 53.3% of chronic kidney disease 
patients. 
3. Incidence of hypothyroidism is 10.7% in CKD patients which is 
higher than that of general population.  
4. Both clinical and biochemical parameters are essential to 
diagnose hypothyroidism in patients with CKD. 
5. Excluding patients with hypothyroidism serum T3 level is low 
(Low T3 Syndrome) in 42.7% of patients and serum T4 is low 
(Low T4 Syndrome) in21.3% of patients with CKD. 
6. Number of patients with low T3 progressively increases with 
severity of renal failure. 
7. Means Serum T3 level has a linear correlation with the severity of 
renal disease. 
8. Number of patients having low T4 and mean serum T4 level does 
not correlate with severity of renal failure. 
9. Blood Hemoglobin level has a linear correlation with severity of 
renal failure. 
10. Alteration in the values of T3 and T4 are a part of body adaptation 
mechanism to conserve energy. 
11. Serum TSH level is normal in all stages of CKD excluding 
primary hypothyroidism. 

Summary
SUMMARY 
 Patients with chronic kidney diseases have many symptoms and 
signs suggestive of thyroid dysfunction. It is very difficult to exclude the 
diagnosis of hypothyroidism on clinical grounds. So a study was 
conducted in CKD patients to study the prevalence and types of thyroid 
dysfunction and the correlation between thyroid dysfunction and 
severity of renal insufficiency if any. 
Seventy five CKD patients on conservative management admitted 
in Institute of Internal Medicine Madras Medical College and 
Government General Hospital, Chennai were studied after taking 
consent. A detailed history and clinical examination were done. 
Investigations including serum T3, T4, TSH were done. 
Eight patients had low serum T3, T4 and  high TSH value of more 
than 20 µIU/ml. These patients were grouped under "Primary 
hypothyroidism". Hypothyroidism incidence in CKD in this study is 
10.67%. Low T3 syndrome incidence was 42.67%. No thyroid 
dysfunction occurs in 46.67% of CKD patients. Low T3 syndrome and 
mean serum T3 level had a linear correlation with severity of renal 
failure which was statistically significant. 
Number of patients with low T4 was 21.33% after excluding 
hypothyroidism patients. The incidence of low T4 and mean serum T4 
level does not correlate with severity of  renal insufficiency. The mean 
value of serum TSH is within normal limits in all stages of renal failure 
excluding hypothyroidism. 
 Anemia was almost always present in CKD patients. As the 
hemoglobin decreases the incidence of low T3 syndrome increased. The 
mean serum T3 and T4 had a linear correlation with hemoglobin level 
which was statistically significant. To conclude thyroid dysfunction 
occurs both clinically and biochemically in patients with CKD. Both 
clinical and biochemical parameters are essential to diagnose 
hypothyroidism in these patients.     
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Proforma 
PROFORMA 
THYROID PROFILE IN CHRONIC KIDNEY DISEASE 
NAME     AGE / SEX 
IP NO.     WEIGHT 
     HEIGHT  
COMPLAINTS    DURATION 
Breathlessness 
Pedal Edema 
Oliguria 
Fatigue, weakness 
Cold intolerance 
Hoarse voice 
Dry Sin 
Weight Gain 
Constipation 
Sleep Disturbance 
Others 
PAST HISTORY 
Hypertension   : Y / N 
Diabetes Mellitus   : Y / N 
Drugs     : Y / N 
Jaundice    : Y / N 
Trauma / Recent Surgery  : Y / N 
Other Systemic Illness  : Y / N 
MENSTRUAL AND OBSTETRIC HISTORY 
GENERAL EXAMINATION  
Nourishment    PR 
Pallor      BP 
Facial Puffiness    BP 
Pedal Edema 
Skin Texture    RR 
Thyroid Swelling 
      TEMP 
CVS 
RS 
Abdomen 
CNS 
INVESTIGATION  
Hb  gm/dl 
TC  Cells / cumm 
DC  P % L % E % 
ESR 
Peripheral Smear 
Urea  : mg/dl 
Creatinine : mg/dl 
Sugar  : mg/dl 
Na+  : MEq/L 
K+  : Meq/L 
Ca++  : mg/dl 
Po43-  : mg/dl 
URINE EXAMINATION 
Albumin 
Sugar 
Deposits 
LIVER FUNCTIONS TESTS 
T. Protein : g/dl 
 Albumin : g/dl 
 Globulin : g/dl 
Serum Lipid Profile 
 Cholesterol : mg/dl 
Creatinine Clearance : ml/min 
12 Lead ECG 
CHEST X RAY 
USG ABDOMEN 
Thyroid Profile  
 T3 : ng/ml 
 T4 : µg/dl 
 TSH : µIU/ml 

Master Chart 
MASTER CHART 
  
Renal parameters Thyroid Profile 
Sl. 
No. Name Age Sex I.P.No. 
Symptoms 
Duration 
Hemoglo
bin g/dl Urea
mg/dl 
Creatinine 
mg/dl 
Creatinine 
clearance ml/min 
Ultrasound 
abdomen T3 
ng/ml 
T4 
µg/ml 
TGH 
µIU/ml 
Miscell-
aneous 
Rajamanickam 40 M 782575 24 months 6.8 138 8.2 9 1 0.5 7.4 0.8 1 
Shanawaz 20 M 784263 8 months 9.6 116 4.8 17 1 0.7 5.8 2.0 1 
Lakshmi 58 F 797437 6 months 10.8 65 2.4 18 1 0.3 7.2 1.9  
Kesavan 56 M 799818 12 months 9.2 88 4.2 13 1 1.9 6.7 0.8 1 
Periyadurai 50 M 800875 6 months 10.6 79 2.8 22 1 1.1 6.1 2.1  
Kettyvel 70 M 801409 24 months 11.2 82 2.3 20 1 0.5 3.1 1.4 1 
Jayabalan 28 M 801306 18 months 12.1 90 2.6 38 1 1.9 6.7 5.2  
Sigamani 52 M 800069 5 months 8.4 105 4.5 14 2 0.2 2.1 28.5 1 
Samudeen 55 M 801707 4 months 7.8 112 5.8 10 1 0.3 6.7 2.1 1 
Varghees 76 M 801756 12 months 9.1 92 2.8 16 1 0.7 7.1 3.1 1, 2 
Natarajan 52 M 799584 4 months 8.2 73 2.4 21 1 1.9 6.9 2.9 2 
Ramamoorthy 35 M 800363 24 months 6.4 124 6.3 13 1 0.3 6.2 12.7 1 
Panneerselvam 38 M 800399 12 months 10.8 78 4.6 34 1 0.7 9.2 2.7  
Renal parameters Thyroid Profile 
Sl. 
No. Name Age Sex I.P.No. 
Symptoms 
Duration 
Hemoglo
bin g/dl Urea
mg/dl 
Creatinine 
mg/dl 
Creatinine 
clearance ml/min 
Ultrasound 
abdomen T3 
ng/ml 
T4 
µg/ml 
TGH 
µIU/ml 
Miscell-
aneous 
Munusamy 52 M 803620 6 months 11.4 81 3.6 22 1 0.8 8.3 1.0 1 
Ettayan 57 M 802627 8 months 11.8 67 2.7 24 1 0.5 3.7 1.3  
Nagarajan 50 M 805401 24 months 7.8 68 3.4 14 1 0.3 1.1 25 1 
Muthaiyan 62 M 805194 18 months 7.9 76 4.2 13 1 0.7 5.7 1.9 1 
Sangeetha 20 F 807931 6 months 10.8 68 3.1 25 1 0.5 3.6 12.5 1 
Panneerselvam 43 M 809013 8 months 7.2 98 5.0 11 1 0.2 7.9 1.2  
Velu 60 M 804894 4 months 10.8 78 2.6 20 2 0.7 8.9 3.4 2 
Gopal 60 M 804823 12 months 4.8 125 6.1 8 1 0.4 2.6 1.2 1 
Egambaram 72 M 810895 4 months 5.2 102 4.2 10 1 0.8 7.9 1.9 1 
Seetharaman 67 M 810880 30 months 11.1 87 2.8 24 1 0.4 2.6 24.0 1, 2 
Saraswathy 55 F 809858 4 months 10.2 110 2.4 28 1 1.2 7.2 6.2 4 
Pattabiram 54 M 811343 12 months 6.9 88 3.6 18 1 0.3 7.4 2.9 1 
Ponnamma 58 F 817081 36 months 5.1 110 5.2 10 2 0.4 6.4 11.6 1 
Anbu 30 M 810181 24 months 8.9 88 4.8 20 1 1.7 7.1 0.8  
Renal parameters Thyroid Profile 
Sl. 
No. Name Age Sex I.P.No. 
Symptoms 
Duration 
Hemoglo
bin g/dl Urea
mg/dl 
Creatinine 
mg/dl 
Creatinine 
clearance ml/min 
Ultrasound 
abdomen T3 
ng/ml 
T4 
µg/ml 
TGH 
µIU/ml 
Miscell-
aneous 
Munivel 60 M 812877 8 months 7.0 84 5.0 12 1 0.5 3.2 2.3 1 
Kalaiselvan 30 M 815110 8 months 10.4 79 3.1 31  2.0 7.3 2.1 1 
Durai 38 M 815053 12 months 9.8 107 4.6 18 1 0.2 7.9 3.6  
Natesan 48 M 811860 18 months 6.2 124 8.2 10 1 0.3 3.2 3.1 1 
Rajalingam 52 M 818276 4 months 8.2 84 2.2 36 1 1.0 8.1 1.1 1 
Rangasamy 47 M 817952 6 months 7.8 95 6.1 12 1 0.5 3.6 14.5 3 
krishnan 65 M 818859 4 months 9.8 78 3.0 20 1 0.4 9.6 3.7 2 
Pushpavathy 48 F 819941 8 months 11.8 146 4.4 12 1 0.4 4.1 26.0 1 
Chellamma 36 F 821874 6 months 12.4 78 2.2 38 1 1.7 8.9 5.6  
Usena 45 F 823487 8 months 8.2 92 3.6 16 1 0.5 4.1 3.2 1 
Thangavel 65 M 820352 4 months 7.6 68 3.0 18 1 0.7 6.1 0.5 1 
Ponnudurai 55 M 823695 6 months 9.8 79 2.6 31 1 0.8 6.7 3.5 1 
Ashokan 40 M 824023 3 months 7.6 124 7.6 10 2 0.5 2.4 25.0 1, 2 
Purushothaman 54 M 821183 4 months 9.8 112 4.9 13 1 0.8 9.1 1.9 4 
Renal parameters Thyroid Profile 
Sl. 
No. Name Age Sex I.P.No. 
Symptoms 
Duration 
Hemoglo
bin g/dl Urea
mg/dl 
Creatinine 
mg/dl 
Creatinine 
clearance ml/min 
Ultrasound 
abdomen T3 
ng/ml 
T4 
µg/ml 
TGH 
µIU/ml 
Miscell-
aneous 
Periyasamy 50 M 828518 6 months 10.2 87 3.5 18 2 0.3 8.2 10.5 1 
Velmurugan 22 M 824531 8 months 4.2 163 13.6 8 1 0.2 1.7 7.6 3 
Saravanan 35 M 825135 12 months 6.4 185 10.4 8 1 0.3 6.1 1.8 1 
Raja 26 M 824239 6 months 6.9 96 4.6 18 1 0.7 5.5 0.7 1 
Palani 40 M 824324 4 months 10.4 82 2.8 31 1 1.1 7.9 2.3 1 
Narayanasami 55 M 825916 3 months 7.9 82 3.4 14 2 0.5 4.1 1.7  
Gunasekaran 41 M 825977 15 months 8.4 82 3.3 24 1 0.4 1.5 27.0 1 
Chinnaiya 62 M 824689 6 months 8.2 78 3.1 20 1 0.7 5.8 1.3  
Parthasarathy 65 M 826661 6 months 6.9 83 3.4 12 1 1.0 7.0 0.8 1 
Boopathy 42 M 825156 8 months 11.4 72 2.8 36 1 0.5 7.0 14.0 2 
Krishnan 57 M 827184 4 months 7.4 71 2.8 18 1 0.2 3.1 1.4 1 
Rajinath 55 F 826637 24 months 6.9 92 4.2 12 1 1.3 6.1 1.2 1 
Suryakandha 65 F 826822 6 months 8.2 80 2.8 20 1 0.9 7.1 1.4 1 
Arputham 28 F 826264 6 months 10.4 72 2.7 18 2 0.3 0.8 26.5 1 
Renal parameters Thyroid Profile 
Sl. 
No. Name Age Sex I.P.No. 
Symptoms 
Duration 
Hemoglo
bin g/dl Urea
mg/dl 
Creatinine 
mg/dl 
Creatinine 
clearance ml/min 
Ultrasound 
abdomen T3 
ng/ml 
T4 
µg/ml 
TGH 
µIU/ml 
Miscell-
aneous 
Periyasamy 53 M 828228 8 months 10.2 77 3.4 17 1 0.7 6.4 1.0  
Sami 58 M 828560 4 months 9.6 68 2.4 22 1 0.9 6.1 0.7  
Govindasami 44 M 829444 3 months 11.2 74 2.6 34 1 0.7 6.2 2.1 1 
Murugan 35 M 828026 24 months 4.7 170 14.7 7 1 0.2 2.2 13.5 3 
Vincent 50 M 832631 6 months 8.2 82 3.2 16 1 0.4 8.9 2.1 2 
Sekar 37 M 833794 9 months 9.4 96 4.2 13 1 0.2 3.2 6.3  
Munaram 30 M 833619 12 months 7.2 81 6.4 11 1 0.4 2.1 3.1 1 
Arundoss 20 M 832247 4 months 10.4 74 3.2 36 1 0.9 7.1 2.4 1 
Ajesh 42 M 832237 6 months 9.8 96 3.2 24 2 0.5 3.9 3.1  
Sundaralingam 47 M 838135 12 months 7.2 115 5.1 10 1 1.1 7.9 2.1 1 
Stellamary 24 F 833480 12 months 5.2 154 8.2 8 1 0.2 6.1 1.3 1 
Mannarammal 65 F 834372 4 months 7.8 82 2.6 13 1 0.4 3.1 1.1 4 
Chakkamma 50 F 832367 6 months 9.2 84 3.1 17 1 1.2 5.7 1.3 1 
Duraisamiammal 56 F 831248 8 months 8.2 160 4.2 10 2 0.7 5.8 0.7 1, 2 
Renal parameters Thyroid Profile 
Sl. 
No. Name Age Sex I.P.No. 
Symptoms 
Duration 
Hemoglo
bin g/dl Urea
mg/dl 
Creatinine 
mg/dl 
Creatinine 
clearance ml/min 
Ultrasound 
abdomen T3 
ng/ml 
T4 
µg/ml 
TGH 
µIU/ml 
Miscell-
aneous 
Pataiyan 55 M 808971 6 months 7.9 98 5.1 12 1 0.8 6.3 1.7  
Rahman Sheriff 54 M 831585 24 months 8.2 122 5.7 10 1 0.3 3.2 24.5 1 
Lakshmi Kandha 38 F 834889 3 months 10.2 76 2.4 35 1 0.5 7.2 5.1 2 
Padrattan 66 M 837204 3 months 7.8 82 2.3 18 1 0.4 5.5 13.5 2 
Suresh Babu 40 M 836500 6 months 8.9 90 2.5 34 2 0.8 6.2 1.5  
Shankar 42 M 836778 12 months 12.2 102 3.1 28 1 0.9 6.9 0.9 1 
 
 
 
ULTRASOUND ABDOMEN 
 
1 - Bilaterally Contracted Kidneys 
2 - Corticomedullary Differentiation Lost 
 MISCELLANEOUS  
 
1 - Hyptothyroid symptoms present 
2 - Delayed Ankle Jerk 
3 - Papilledema present 
4 - Goitre Present 
 
 
